These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2642127)

  • 1. A review of 20 cases of spastic dysphonia.
    Whyte S; Darveniza P
    Clin Exp Neurol; 1989; 26():177-81. PubMed ID: 2642127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging concepts in muscle tension dysphonia: a 30-month review.
    Altman KW; Atkinson C; Lazarus C
    J Voice; 2005 Jun; 19(2):261-7. PubMed ID: 15907440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spastic/spasmodic vs. tremulous vocal quality: motor speech profile analysis.
    Lundy DS; Roy S; Xue JW; Casiano RR; Jassir D
    J Voice; 2004 Mar; 18(1):146-52. PubMed ID: 15070235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox).
    Brin MF; Blitzer A; Fahn S; Gould W; Lovelace RE
    Mov Disord; 1989; 4(4):287-96. PubMed ID: 2811888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adduction spastic dysphonia: clinical and treatment].
    García Ruiz PJ; Sánchez del Río M; Cenjor Español C; Sanabria Brassart J; Sánchez Bernardos V; Astarloa Gómez R; García de Yébenes J
    Rev Clin Esp; 1998 Mar; 198(3):156-8. PubMed ID: 9586438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory and laryngeal function during spontaneous speaking in teachers with voice disorders.
    Lowell SY; Barkmeier-Kraemer JM; Hoit JD; Story BH
    J Speech Lang Hear Res; 2008 Apr; 51(2):333-49. PubMed ID: 18367681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Task specificity in adductor spasmodic dysphonia versus muscle tension dysphonia.
    Roy N; Gouse M; Mauszycki SC; Merrill RM; Smith ME
    Laryngoscope; 2005 Feb; 115(2):311-6. PubMed ID: 15689757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and demographics in patients with spasmodic dysphonia.
    Schweinfurth JM; Billante M; Courey MS
    Laryngoscope; 2002 Feb; 112(2):220-3. PubMed ID: 11889373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The present status of adductor spastic dysphonia.
    Stoicheff ML
    J Otolaryngol; 1983 Oct; 12(5):311-4. PubMed ID: 6644860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle tension dysphonia in patients who use computerized speech recognition systems.
    Olson DE; Cruz RM; Izdebski K; Baldwin T
    Ear Nose Throat J; 2004 Mar; 83(3):195-8. PubMed ID: 15086016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of risk factors for spasmodic dysphonia: A comparison with other voice disorders.
    Tanner K; Roy N; Merrill RM; Sauder C; Houtz DR; Smith ME
    Laryngoscope; 2012 May; 122(5):1082-92. PubMed ID: 22253036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adductor spastic dysphonia as a sign of essential (voice) tremor.
    Aronson AE; Hartman DE
    J Speech Hear Disord; 1981 Feb; 46(1):52-8. PubMed ID: 7206678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory characteristics of focal laryngeal dystonia: study of 110 cases.
    Blitzer A; Brin MF; Fahn S; Lovelace RE
    Laryngoscope; 1988 Jun; 98(6 Pt 1):636-40. PubMed ID: 3374239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD; Sapienza CM; Bidus K; Ludlow CL
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of gastroesophageal reflux disease in patients with laryngeal and voice disorders.
    Makhadoom N; Abouloyoun A; Bokhary HA; Dhafar KO; Gazzaz ZJ; Azab BA
    Saudi Med J; 2007 Jul; 28(7):1068-71. PubMed ID: 17603713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic difficulties in spasmodic dysphonia--case report].
    Szkiełkowska A; Miaśkiewicz B; Baczyńska-Swierczyńska S; Szymańska E
    Pol Merkur Lekarski; 2006 May; 20(119):557-9. PubMed ID: 16875162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Listening: the key to diagnosing spasmodic dysphonia.
    Braden MN; Hapner ER
    ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of patients' subjective responses to botulinum toxin injection for spasmodic dysphonia.
    Liu TC; Irish JC; Adams SG; Durkin LC; Hunt EJ
    J Otolaryngol; 1996 Apr; 25(2):66-74. PubMed ID: 8683655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.